Horizon Therapeutics PLC
NASDAQ:HZNP
Horizon Therapeutics PLC
Selling, General & Administrative
Horizon Therapeutics PLC
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Horizon Therapeutics PLC
NASDAQ:HZNP
|
Selling, General & Administrative
-$1.7B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-35%
|
|
Alkermes Plc
NASDAQ:ALKS
|
Selling, General & Administrative
-$693.5m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-16%
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Selling, General & Administrative
-$180.3m
|
CAGR 3-Years
25%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-6%
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Selling, General & Administrative
-$65.5m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-15%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Selling, General & Administrative
-$30.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Horizon Therapeutics PLC's Selling, General & Administrative?
Selling, General & Administrative
-1.7B
USD
Based on the financial report for Jun 30, 2023, Horizon Therapeutics PLC's Selling, General & Administrative amounts to -1.7B USD.
What is Horizon Therapeutics PLC's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-35%
Over the last year, the Selling, General & Administrative growth was -8%. The average annual Selling, General & Administrative growth rates for Horizon Therapeutics PLC have been -26% over the past three years , -20% over the past five years , and -35% over the past ten years .